6505--Montelukast 10mg Tablet (VA-25-00102867)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
PRE-SOLICITATION NOTICE:Â The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0020 for an unrestricted procurement for Montelukast 10mg Tablet, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).Â
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.Â
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 4, 30 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.Â
Solicitation # 36E79725R0061 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 30, 2025, with a tentative closing date of October 10, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Kenneth Lay. Questions can be e-mailed to Kenneth.Lay@va.gov. Â
The estimated annual requirements are as follows:Â
REQUIREMENT DESCRIPTIONÂ
ITEMÂ
DESCRIPTIONÂ
PACKAGE SIZE (Tablets per Bottle)Â
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
MONTELUKAST NA 10MG TAB
30
62,485
2
MONTELUKAST NA 10MG TAB
90
699,070
3a
MONTELUKAST NA 10MG TAB
500
77,256
OR
OR
OR
3b
MONTELUKAST NA 10MG TAB
1000
38,628